Search
for
Sort by
Research 511–540 of 670
- Telemedicine Alopecia Assessment: Highlighting Patients With Skin of Color
- Nutritional Dermatoses in the Hospitalized Patient
- Acute Alopecia Associated With Albendazole Toxicosis
- Permanent Alopecia in Breast Cancer Patients: Role of Taxanes and Endocrine Therapies
- Cutaneous Signs of Malnutrition Secondary to Eating Disorders
- Alopecia Areata in Skin of Color Patients: New Considerations Sparked by the Approval of Baricitinib
- Cutaneous Manifestations of COVID-19
- Androgenetic Alopecia: What Works?
- Culprits of Medication-Induced Telogen Effluvium, Part 2
- Culprits of Medication-Induced Telogen Effluvium, Part 1
- Alopecia Universalis Treated With Tofacitinib: The Role of JAK/STAT Inhibitors in Hair Regrowth
- Imaging Tools for Noninvasive Hair Assessment
- Hair Repigmentation as a Melanoma Warning Sign
- The Evidence Behind Topical Hair Loss Remedies on TikTok
- Acute Alopecia Associated With Albendazole Toxicosis
- Ischemia-modified albumin as a possible marker of oxidative stress in patients with telogen effluvium
- Long-term sequelae of drug reaction with eosinophilia and systemic symptoms: A retrospective cohort study from Taiwan
- Hair shape of curly hair
- Management of patients and side effects during cyclosporine therapy for cutaneous disorders
- Erosive pustular dermatosis of the scalp following topical methylaminolaevulinate photodynamic therapy
- Benefit of different concentrations of intralesional triamcinolone acetonide in alopecia areata: An intrasubject pilot study
- Expression of the heat shock protein-27 in the adult human scalp skin and hair follicle: Hair cycle–dependent changes
- Follicular mucinous nevus: A possible new variant of mucinous nevus
- HIV and alopecia universalis
- The prevalence of skin diseases in Greece, impact on quality of life and stigmatization: A population‐based survey study
- Extensive scleredema adultorum with loss of eccrine glands
- Woman with hyperpigmented plaque and alopecia
- Hair disorders associated with autoimmune connective tissue diseases
- 62045 Dermatologist Utilization of Medications Associated with Androgenic Alopecia Treatment Among Medicare Beneficiaries
- No increased risk of mood disorders in male androgenetic alopecia patients treated with dutasteride and finasteride: a retrospective cohort database study